Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /CBDL

CBD Life Sciences Inc.

CBDL

• OTCMKTS: CBDL • Delayed

0.0004USD 33%

As of 13 June 2026, CBD Life Sciences Inc. has a market cap of $1.99M USD, ranking #47204 globally and #5996 in the United States. It ranks #4180 in the Healthcare sector, and #319 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

47204

Country Rank

5996

Sector Rank

4180

Industry Rank

319

Key Stats

Market Cap

$1.99MUSD

Revenue (TTM)

$178.45KUSD

EBITDA (TTM)

-$51.88KUSD

Net Income (TTM)

-$107.44KUSD

EBITDA Margin

-29%

Profit Margin

-60%

PS Ratio

11.2

PB Ratio

5.8

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Lisa Nelson open_in_new

Employees

Website

thecbdvault.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
33%	33%	300%	100%	100%	100%	0%	33%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	CBDL CBD Life Sciences Inc ISIN: US12482V2025 Shares Out.: Shares Outstanding: 5.697B¹ TV: TradingView: OTC: CBDL SA: Stock Analysis: OTC: CBDL YF: Yahoo Finance: CBDL GF: Google Finance: OTCMKTS: CBDL BA: Barron's: CBDL MS: Morningstar: PINX: CBDL	0.0004 USD	TV: TradingView: OTC: CBDL SA: Stock Analysis: OTC: CBDL YF: Yahoo Finance: CBDL GF: Google Finance: OTCMKTS: CBDL BA: Barron's: CBDL MS: Morningstar: PINX: CBDL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About CBD Life Sciences Inc.

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)

Name	Market Cap (USD) diff.	PE	Country
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 1M%	-	United States
Indivior PLC LSE: INDV	$2.07B 1.54B GBP 104K%	-	United States
Endo, Inc. OTCMKTS: NDOI	$1.8B 90K%	0.4	United States
Dynavax Technologies Corp. NASDAQ: DVAX	$1.76B 88K%	-	United States
ArriVent BioPharma, Inc. NASDAQ: AVBP	$1.33B 67K%	-	United States
BellRing Brands, Inc. NYSE: BRBR	$1.02B 51K%	12.1	United States

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 2M%	24.2	Israel
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 794K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 560K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 554K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 456K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 438K%	-	France

chevron_leftBack